URGN UroGen Pharma Ltd.
UroGen Pharma Ltd. (URGN) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors Growth Healthcare | Sold Out | -1.70M | -100.0% | $62.7M | 0.0% | 69 |
| Point72 Asset Management, L.P. | New | +1.53M | — | $56.1M | 0.1% | 66 |
| Tang Capital Management Growth Healthcare | Sold Out | -350.0K | -100.0% | $12.9M | 0.0% | 61 |
| Vestal Point Capital Growth Healthcare | Sold Out | -139.1K | -100.0% | $5.1M | 0.0% | 61 |
| RENAISSANCE TECHNOLOGIES LLC Quant | New | +70.3K | — | $2.6M | 0.0% | 60 |
| Farallon Capital Management Event Value | Sold Out | -11.0K | -100.0% | $404.8K | 0.0% | 60 |
| Squarepoint Ops LLC Quant | New | +11.7K | — | $430.5K | 0.0% | 54 |
| ExodusPoint Capital Management Long/Short Quant | Sold Out | -70.2K | -100.0% | $2.6M | 0.0% | 54 |
| Trexquant Investment Quant | Sold Out | -73.9K | -100.0% | $2.7M | 0.0% | 53 |
| Capital Fund Management Quant Macro | New | +17.6K | — | $647.1K | 0.0% | 53 |
Most significant buyers
By move score, not size.
- Point72 Asset Management, L.P.
- RENAISSANCE TECHNOLOGIES LLC
- Squarepoint Ops LLC
- Capital Fund Management
- Jain Global
Most significant sellers
By move score, not size.
- Paradigm BioCapital Advisors
- Tang Capital Management
- Vestal Point Capital
- Farallon Capital Management
- ExodusPoint Capital Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors | 1 | 0 | 1.7M | -1.70M | -100.0% | 0.0% | Sold Out | 69 |
| Point72 Asset Management, L.P. | 1 | 1.5M | 0 | +1.53M | — | 0.1% | New | 66 |
| Tang Capital Management | 2 | 0 | 350.0K | -350.0K | -100.0% | 0.0% | Sold Out | 61 |
| Vestal Point Capital | 1 | 0 | 139.1K | -139.1K | -100.0% | 0.0% | Sold Out | 61 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 70.3K | 0 | +70.3K | — | 0.0% | New | 60 |
| Farallon Capital Management | 1 | 0 | 11.0K | -11.0K | -100.0% | 0.0% | Sold Out | 60 |
| Squarepoint Ops LLC | 2 | 11.7K | 0 | +11.7K | — | 0.0% | New | 54 |
| ExodusPoint Capital Management | 3 | 0 | 70.2K | -70.2K | -100.0% | 0.0% | Sold Out | 54 |
| Trexquant Investment | 3 | 0 | 73.9K | -73.9K | -100.0% | 0.0% | Sold Out | 53 |
| Capital Fund Management | 3 | 17.6K | 0 | +17.6K | — | 0.0% | New | 53 |
| CITADEL ADVISORS LLC | 1 | 13.0K | 268.0K | -255.0K | -95.2% | 0.0% | Reduced | 53 |
| Man Group | 3 | 0 | 25.4K | -25.4K | -100.0% | 0.0% | Sold Out | 52 |
| Jain Global | 3 | 6.9K | 0 | +6.9K | — | 0.0% | New | 52 |
| Caption Management | 3 | 0 | 4.1K | -4.1K | -100.0% | 0.0% | Sold Out | 50 |
| Engineers Gate | 4 | 16.4K | 0 | +16.4K | — | 0.0% | New | 48 |
| J. Goldman & Co. | 3 | 212.8K | 938.9K | -726.1K | -77.3% | 0.3% | Reduced | 47 |
| MILLENNIUM MANAGEMENT LLC | 2 | 106.7K | 370.9K | -264.2K | -71.2% | 0.0% | Reduced | 46 |
| Quantbot Technologies | 4 | 2.1K | 0 | +2.1K | — | 0.0% | New | 45 |
| Schonfeld Strategic Advisors | 3 | 32.5K | 158.1K | -125.7K | -79.5% | 0.0% | Reduced | 42 |
| Voloridge Investment Management | 2 | 111.1K | 230.6K | -119.5K | -51.8% | 0.0% | Reduced | 37 |
| Soleus Capital Management | 2 | 829.8K | 727.0K | +102.8K | +14.1% | 1.1% | Increased | 37 |
| OrbiMed Advisors | 2 | 676.2K | 875.5K | -199.3K | -22.8% | 0.5% | Reduced | 36 |
| ADAR1 Capital Management | 3 | 252.4K | 395.5K | -143.1K | -36.2% | 0.5% | Reduced | 35 |
| D. E. Shaw & Co., Inc. | 1 | 1.1M | 1.0M | +122.7K | +12.0% | 0.0% | Increased | 32 |
| TWO SIGMA INVESTMENTS, LP | 2 | 149.0K | 177.9K | -28.9K | -16.3% | 0.0% | Reduced | 32 |
| AQR Capital Management | 3 | 149.2K | 144.1K | +5.2K | +3.6% | 0.0% | Increased | 21 |
| RTW Investments | 1 | 4.5M | 4.5M | 0 | +0.0% | 1.4% | Unchanged | 32 |
| Woodline Partners LP | 2 | 500.7K | 500.7K | 0 | +0.0% | 0.1% | Unchanged | 18 |
| Palo Alto Investors | 2 | 24.5K | 24.5K | 0 | +0.0% | 0.1% | Unchanged | 20 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.